Relationship between CRP and hypofibrinolysis: Is this a possible mechanism to explain the association between CRP and outcome in critically ill patients?

Thrombosis Journal

Volumn 2, Issue , 2004, Pages

  Boudjeltia, Karim Zouaoui ^a   Piagnerelli, Michael ^b   Brohée, Dany ^a   Guillaume, Michel ^a   Cauchie, Philippe ^a   Vincent, Jean Louis ^b   Remacle, Claude ^c   Bouckaert, Yves ^d   Vanhaeverbeek, Michel ^a  

^a CHU Andre Vesale   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d Tivoli Hospital   (Belgium)

Author keywords

Acute phase reactant; C reactive protein; Endothelium dysfunction; Euglobulin clot lysis time; Inflammation; Sepsis

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT PROTEIN;

ACUTE PHASE RESPONSE; ADULT; AGED; AORTA; ARTICLE; AUTOMATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICAL ILLNESS; DEATH; ENDOTHELIUM CELL; EUGLOBULIN LYSIS TEST; FIBRIN DEPOSITION; FIBRINOLYSIS; HOSPITALIZATION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; MICROANGIOPATHY; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RISK FACTOR; SEPSIS; TIME;

EID: 23944517423     PISSN: 14779560     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-2-7     Document Type: Article

References (23)

1. Levi M, ten Cate H, van der Poll T: Endothelium: interface between coagulation and inflammation. Crit Care Med 2002, 30:S220-S224.
2. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101:3765-3777.
3. Idell S: Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003, 31:S213-S220.
4. Gross PL, Aird WC: The endothelium and thrombosis. Semin Thromb Hemost 2000, 26:463-478.
5. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C, Vincent JL: C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003, 123:2043-2049.
6. Blann AD, Lip GY: Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells. Blood Coagul Fibrinolysis 2003, 14:335-340.
7. Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA: Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002, 105:1890-1896.
8. Devaraj S, Xu DY, Jialal I: C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 2003, 107:398-404.
9. Bisoendial RJ, Kasteleuin JJ, Levels JHM, Zwaginga JJ, Van den Bogaard B, Reitsma PH, Meijers CM, Hartman D, Levi M, Stroes ESG: Activation of inflammation and Coagulation after infusion of C-reactive protein in humans. Lancet in press.
10. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference. Crit Care Med 2003, 31:1250-1256.
11. Le Gall JR, Loirat P, Alperovitch A, Glaser P, Granthil C, Mathieu D, Mercier P, Thomas R, Villers D: A simplified acute physiologic score for ICU patients. Crit Care Med 1984, 12:975-977.
12. Urano T, Sakakibara K, Rydzewski A, Urano S, Takada Y, Takada A: Relationship netween euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1. Thrombosis Haemostasis 1990, 63:82-86.
13. Boudjeltia KZ, Cauchie P, Remacle C, Guillaume M, Brohee D, Hubert JL, Vanhaeverbeek M: A new device for measurement of fibrin clot lysis: application to the euglobulin clot lysis time. BMC Biotechnol 2002, 2:8.
14. Bombeli T, Mueller M, Haeberli A: Anticoagulant properties of the vascular endothelium. Thromb Haemost 1997, 77:408-423.
15. Cleland SJ, Sattar N, Petrie JR, Forouhi NG, Elliott HL, Connell JM: Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci (Lond) 2000, 98:531-535.
16. Shah SH, Newby LK: C-reactive protein: a novel marker of cardiovascular risk. Cardiol Rev 2003, 11:169-179.
17. Zouaoui Boudjeltia K, Guillaume M, Kinard F, Cauchie P, Remacle C, Ducobu J, Vanhaeverbeek M, Brohee D: Effect of blood monocyte counts on plasma fibrinolytic capacity. Atherosclerosis 2001, 2:83 (abstract).
18. Mesters RM, Florke N, Ostermann H, Kienast J: Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis. Thromb Haemost 1996, 75:902-907.
19. Oberhoffer M, Karzai W, Meier-Hellmann A, Bogel D, Fassbinder J, Reinhart K: Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis. Crit Care Med 1999, 27:1814-1818.
20. Ballou SP, Lozanski G: Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992, 4:361-368.
21. Cao H, Hegele RA: Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet 2000, 45(2):100-1.
22. Szalai AJ, Briles DE, Volanakis JE: Human C-reactive protein is protective against fatal streptococcus pneumoniae infection in transgenic mice. The journal of immunology 1995, 155:2557-2563.
23. Szalai AJ, VanCott JL, McGhee JR, Volonakis JE, Benjamin WH: Human C-reactive protein is protective against fatal Salmonella enterica Serovar Typhimurium infection in Transgenic Mice. Infection and Immunity 2000, 68(10):5652-5656.